Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly M McKenna

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|June 28, 2023
Gene knock-outs in human CD34+ hematopoietic stem and progenitor cells and in the human immune system of miceDaniel A Kuppers, Jonathan Linton, Sergio Ortiz Espinosa, et al.
Frontiers in Immunology|March 11, 2021
Building the Next Generation of Humanized Hemato-Lymphoid System MiceTijana Martinov, Kelly M McKenna, Wei Hong Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and BtkMingye Feng, James Y Chen, Rachel Weissman-Tsukamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activityNan Guo Ring, Dietmar Herndler-Brandstetter, Kipp Weiskopf, et al.
Cancer Immunology Research|November 19, 2016
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20Kipp Weiskopf, Katie L Anderson, Daisuke Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
An In Vivo Model of Human Macrophages in Metastatic MelanomaValentin Voillet, Trisha R Berger, Kelly M McKenna, et al.
Science Translational Medicine|November 30, 2018
Surgical adhesions in mice are derived from mesothelial cells and can be targeted by antibodies against mesothelial markersJonathan M Tsai, Rahul Sinha, Jun Seita, et al.
Nature Immunology|November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyAmira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|June 28, 2023
Gene knock-outs in human CD34+ hematopoietic stem and progenitor cells and in the human immune system of miceDaniel A Kuppers, Jonathan Linton, Sergio Ortiz Espinosa, et al.
Frontiers in Immunology|March 11, 2021
Building the Next Generation of Humanized Hemato-Lymphoid System MiceTijana Martinov, Kelly M McKenna, Wei Hong Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and BtkMingye Feng, James Y Chen, Rachel Weissman-Tsukamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activityNan Guo Ring, Dietmar Herndler-Brandstetter, Kipp Weiskopf, et al.
Cancer Immunology Research|November 19, 2016
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20Kipp Weiskopf, Katie L Anderson, Daisuke Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
An In Vivo Model of Human Macrophages in Metastatic MelanomaValentin Voillet, Trisha R Berger, Kelly M McKenna, et al.
Science Translational Medicine|November 30, 2018
Surgical adhesions in mice are derived from mesothelial cells and can be targeted by antibodies against mesothelial markersJonathan M Tsai, Rahul Sinha, Jun Seita, et al.
Nature Immunology|November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyAmira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
Pageof 1